Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
133.50
-0.50 (-0.37%)
Jul 30, 2026, 9:49 AM CST

TPEX:3218 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
960.761,0431,0651,045850.53595.43
Depreciation & Amortization
553.36541.41518.05441.77367.85315.1
Other Amortization
2.182.383.444.384.414.42
Loss (Gain) From Sale of Assets
0.420.628.921.372.220.22
Asset Writedown & Restructuring Costs
16.1716.17----
Loss (Gain) From Sale of Investments
95.0261.89100.22---
Provision & Write-off of Bad Debts
0.09-3.072.444.367.650.32
Other Operating Activities
14.728.63-20.2465.6683.0638.42
Change in Accounts Receivable
8.1154.3216.1-6.76-54.54-158.12
Change in Inventory
-4.56-13.841.8-89.85-111.63-47.32
Change in Accounts Payable
-36.89-43.71-44.2457.7644.0687.56
Change in Other Net Operating Assets
11.93-2120.8529.8274.5775.74
Operating Cash Flow
1,6211,6661,6721,5541,268911.77
Operating Cash Flow Growth
-8.75%-0.34%7.63%22.51%39.09%10.24%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-537.92-562.66-434.65-472.53-489.7-324.44
Sale of Property, Plant & Equipment
0.250.110.860.080.120.07
Sale (Purchase) of Intangibles
-0.81-1.16-2.45-1.68-3.14-4.26
Investment in Securities
-66.1322.06-1,046-1.74-70.81-44.06
Other Investing Activities
-4.05-1.94-1.93-1.08-1.14-7.11
Investing Cash Flow
-608.66-543.59-1,484-476.95-564.66-379.81

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-48.6182.528.85--
Long-Term Debt Issued
-----23.88
Total Debt Issued
48.6148.6182.528.85-23.88
Short-Term Debt Repaid
--46.36----176.49
Long-Term Debt Repaid
--204.53-185.43-177.84-164.22-140.03
Total Debt Repaid
-267.65-250.9-185.43-177.84-164.22-316.52
Net Debt Issued (Repaid)
-219.04-202.29-102.91-168.99-164.22-292.64
Common Dividends Paid
-635.44-635.44-593.07-479.58-380.62-319.72
Other Financing Activities
-25-7.5-67.06-62.0950.03
Financing Cash Flow
-879.48-845.23-763.04-710.65-539.83-612.33

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.53-5.2419.41-6.465.14-1.45
Net Cash Flow
132.62272.39-555.69359.53168.83-81.81

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,0831,1041,2371,081778.47587.33
Free Cash Flow Growth
-18.47%-10.80%14.46%38.87%32.55%10.41%
Free Cash Flow Margin
25.98%26.25%29.27%26.48%22.28%22.32%
Free Cash Flow Per Share
12.7312.9814.5612.739.176.92
Levered Free Cash Flow
725.34784.59922.06820.41574.26411.54
Unlevered Free Cash Flow
741.42800.11935.15830.3582.73419.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.985.265.051.471.212.47
Cash Income Tax Paid
299.01299.11283.54220.7165.62132.78
Change in Working Capital
-21.42-24.23-5.49-9.04-47.55-42.14